Marimed (MRMD) Free Cash Flow Growth (3y) (2016 - 2026)
Marimed (MRMD) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 39.19% |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 30.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.21% |
| Dec 31, 2025 | 4.06% |
| Sep 30, 2025 | -15.06% |
| Jun 30, 2025 | 44.59% |
| Mar 31, 2025 | -38.78% |
| Dec 31, 2024 | 47.64% |
| Sep 30, 2024 | -27.12% |
| Jun 30, 2024 | -40.93% |
| Mar 31, 2024 | -26.48% |
| Dec 31, 2023 | -33.53% |
| Sep 30, 2023 | 88.72% |
| Jun 30, 2023 | -30.94% |
| Mar 31, 2023 | -36.27% |
| Dec 31, 2022 | -34.90% |
| Sep 30, 2022 | 34.92% |
| Jun 30, 2022 | 25.11% |
| Mar 31, 2022 | 37.09% |
| Dec 31, 2021 | -50.07% |
| Sep 30, 2021 | 68.14% |
| Jun 30, 2021 | 59.75% |